Search research articles
Contact Us
Filters
Showing results (71-80 of 902) with videos related to
Page
of 91
Sort By:
Blood Reviews
|
November 11, 2019
New developments in diagnosis, risk assessment and management in systemic amyloidosis
Iuliana Vaxman, Angela Dispenzieri, Eli Muchtar, et al.
The Cochrane Database of Systematic Reviews
|
October 10, 2008
Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome
Satoshi Kuwabara, Angela Dispenzieri, Kimiyoshi Arimura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2018
Validation of Mayo Clinic Staging System for Light Chain Amyloidosis With High-Sensitivity Troponin
Shaji K Kumar, Morie A Gertz, Angela Dispenzieri
Blood Reviews
|
December 20, 2003
Therapy for immunoglobulin light chain amyloidosis: the new and the old
Morie A Gertz, Martha Q Lacy, Angela Dispenzieri
Blood
|
July 24, 2007
Lenalidomide therapy in a patient with POEMS syndrome
Angela Dispenzieri, Christopher J Klein, Michelle L Mauermann
Kidney International
|
January 12, 2002
Immunoglobulin light chain amyloidosis and the kidney
Morie A Gertz, Martha Q Lacy, Angela Dispenzieri
Expert Opinion on Pharmacotherapy
|
April 30, 2010
Amyloidosis and POEMS syndrome
Cheng E Chee, Angela Dispenzieri, Morie A Gertz
Mayo Clinic Proceedings
|
May 19, 2006
Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment
S Vincent Rajkumar, Angela Dispenzieri, Robert A Kyle
Muscle & Nerve
|
July 17, 2015
Thrombocytosis distinguishes POEMS syndrome from chronic inflammatory demyelinating polyneuropathy
Elie Naddaf, Angela Dispenzieri, Jay Mandrekar, et al.
Neurology
|
November 4, 2016
Clinical spectrum of Castleman disease-associated neuropathy
Elie Naddaf, Angela Dispenzieri, Jay Mandrekar, et al.
Page
of 91
Search research articles
Search
Showing results (71-80 of 902) with videos related to
Sort By:
Page
of 91
Blood Reviews
|
November 11, 2019
New developments in diagnosis, risk assessment and management in systemic amyloidosis
Iuliana Vaxman, Angela Dispenzieri, Eli Muchtar, et al.
The Cochrane Database of Systematic Reviews
|
October 10, 2008
Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome
Satoshi Kuwabara, Angela Dispenzieri, Kimiyoshi Arimura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2018
Validation of Mayo Clinic Staging System for Light Chain Amyloidosis With High-Sensitivity Troponin
Shaji K Kumar, Morie A Gertz, Angela Dispenzieri
Blood Reviews
|
December 20, 2003
Therapy for immunoglobulin light chain amyloidosis: the new and the old
Morie A Gertz, Martha Q Lacy, Angela Dispenzieri
Blood
|
July 24, 2007
Lenalidomide therapy in a patient with POEMS syndrome
Angela Dispenzieri, Christopher J Klein, Michelle L Mauermann
Kidney International
|
January 12, 2002
Immunoglobulin light chain amyloidosis and the kidney
Morie A Gertz, Martha Q Lacy, Angela Dispenzieri
Expert Opinion on Pharmacotherapy
|
April 30, 2010
Amyloidosis and POEMS syndrome
Cheng E Chee, Angela Dispenzieri, Morie A Gertz
Mayo Clinic Proceedings
|
May 19, 2006
Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment
S Vincent Rajkumar, Angela Dispenzieri, Robert A Kyle
Muscle & Nerve
|
July 17, 2015
Thrombocytosis distinguishes POEMS syndrome from chronic inflammatory demyelinating polyneuropathy
Elie Naddaf, Angela Dispenzieri, Jay Mandrekar, et al.
Neurology
|
November 4, 2016
Clinical spectrum of Castleman disease-associated neuropathy
Elie Naddaf, Angela Dispenzieri, Jay Mandrekar, et al.
Page
of 91